Clinical Trial Update: Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Treat-and-Extend versus Pro Re Nata regimens of conbercept for age-related macular degeneration; efficacy and safety update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Xiaodong Sun | Conditions: Age-related Macular Degeneration | Phase 4 | Status: UNKNOWN